Concepedia

Rio Nakamura

RN

Statistics

Publications

14

Citations

1.8K

H-Index

13

Active since

2013

Affiliations

Shionogi (Japan)(Current)

Futaba (Japan)

GlaxoSmithKline (United States)

Infectious Disease Consultants

Hartford Hospital

Rio Nakamura is an author at Shionogi (Japan) specializing in antibiotic resistance, antimicrobial resistance, and life sciences.

ORCID

Publications per year

2013–2023

14

Publications

14

<i>In Vitro</i> Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

Akinobu Ito, Takafumi Sato, Merime Ota et al. · Antimicrobial Agents and Chemotherapy · 2017 · 378 citations · Full text

, , +17

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa

Akinobu Ito, Toru Nishikawa, Shuhei Matsumoto et al. · Antimicrobial Agents and Chemotherapy · 2016 · 333 citations · Full text

, , +15

<i>In Vitro</i> Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains

Naoki Kohira, Joshua M. West, Akinobu Ito et al. · Antimicrobial Agents and Chemotherapy · 2015 · 241 citations · Full text

, , +13

<i>In vitro</i>antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Akinobu Ito, Naoki Kohira, Samuel K. Bouchillon et al. · Journal of Antimicrobial Chemotherapy · 2015 · 185 citations · Full text

, , +17

Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases

Tsukasa Ito-Horiyama, Yoshikazu Ishii, Akinobu Ito et al. · Antimicrobial Agents and Chemotherapy · 2016 · 184 citations · Full text

, , +12

1–5 of 14